MERCK & CO. INC.
MRKNYSE🏆 #37 by market capEarnings Oct 29 · PreUS Equity
$890.81▼ $33.14 (−3.72%)
Simulated priceTrack MRK
Get earnings, price moves & breaking news on Telegram
24h▼ 3.7%
7d▲ 489.7%
14d▲ 519.7%
30d▲ 500.6%
ytd▲ 746.1%
1y▲ 1033.9%
🏦Market Cap
$367.26B
Large Cap
📈Revenue Growth (YoY)
+1.2%
Slowing
📊Gross Margin
75.4%
High
💵FCF Margin
24.2%
Strong
⚖️P/S Ratio
5.5x
Fair
Otter Score
64
Fair
MERCK & CO. INC.
MRKAnalyst Ratings
Price
$890.81
Total
19
Raised
16
Lowered
0
Avg PT
$157.58
H / L
$180 / $120
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Scotiabank Merck & Co | Raised | Sector Outperform | 2026-09-29 | $180.00 | −79.80% |
Wolfe Research Merck & Co | Raised | Outperform | 2026-08-25 | $180.00 | −79.80% |
Morgan Stanley Merck & Co | Raised | Equal-Weight → Overweight | 2026-08-20 | $179.00 | −79.90% |
UBS Merck & Co | Raised | Buy | 2026-08-20 | $175.00 | −80.40% |
HSBC Merck & Co | Raised | Buy | 2026-09-10 | $172.00 | −80.70% |
Guggenheim Merck & Co | Raised | Buy | 2026-09-08 | $170.00 | −80.90% |
Wells Fargo Merck & Co | Raised | Overweight | 2026-09-04 | $170.00 | −80.90% |
Argus Research Merck & Co | Raised | Buy | 2026-08-25 | $170.00 | −80.90% |
BMO Capital Merck & Co | Raised | Outperform | 2026-08-20 | $170.00 | −80.90% |
Leerink Partners Merck & Co | Raised | Outperform | 2026-09-09 | $161.00 | −81.90% |
Goldman Sachs Merck & Co | Raised | Buy | 2026-08-21 | $160.00 | −82.00% |
RBC Capital Merck & Co | Raised | Outperform → Sector Perform | 2026-08-20 | $150.00 | −83.20% |
Barclays Merck & Co | Raised | Overweight | 2026-07-29 | $150.00 | −83.20% |
Daiwa Capital Merck & Co | Raised | Neutral → Outperform | 2026-08-12 | $143.00 | −83.90% |
B of A Securities Merck & Co | Raised | Buy | 2026-06-30 | $141.00 | −84.20% |
JP Morgan Merck & Co | Raised | Overweight | 2026-07-13 | $140.00 | −84.30% |
CICC Merck & Co | Initiated | Outperform | 2026-06-24 | $138.00 | −84.50% |
Citigroup Merck & Co | Reiterated | Neutral | 2026-05-06 | $125.00 | −86.00% |
Cantor Fitzgerald Merck & Co | Reiterated | Neutral | 2026-07-06 | $120.00 | −86.50% |
Institution
Scotiabank
Raised · Sector Outperform · 2026-09-29
$180.00
−79.80%
Wolfe Research
Raised · Outperform · 2026-08-25
$180.00
−79.80%
Morgan Stanley
Raised · Equal-Weight → Overweight · 2026-08-20
$179.00
−79.90%
UBS
Raised · Buy · 2026-08-20
$175.00
−80.40%
HSBC
Raised · Buy · 2026-09-10
$172.00
−80.70%
Guggenheim
Raised · Buy · 2026-09-08
$170.00
−80.90%
Wells Fargo
Raised · Overweight · 2026-09-04
$170.00
−80.90%
Argus Research
Raised · Buy · 2026-08-25
$170.00
−80.90%
BMO Capital
Raised · Outperform · 2026-08-20
$170.00
−80.90%
Leerink Partners
Raised · Outperform · 2026-09-09
$161.00
−81.90%
Goldman Sachs
Raised · Buy · 2026-08-21
$160.00
−82.00%
RBC Capital
Raised · Outperform → Sector Perform · 2026-08-20
$150.00
−83.20%
Barclays
Raised · Overweight · 2026-07-29
$150.00
−83.20%
Daiwa Capital
Raised · Neutral → Outperform · 2026-08-12
$143.00
−83.90%
B of A Securities
Raised · Buy · 2026-06-30
$141.00
−84.20%
JP Morgan
Raised · Overweight · 2026-07-13
$140.00
−84.30%
CICC
Initiated · Outperform · 2026-06-24
$138.00
−84.50%
Citigroup
Reiterated · Neutral · 2026-05-06
$125.00
−86.00%
Cantor Fitzgerald
Reiterated · Neutral · 2026-07-06
$120.00
−86.50%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space